Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02665650
Brief Title: Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

First Submitted : January 25, 2016
First Submitted that Met QC Criteria : January 27, 2016
First Posted : January 28, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 15, 2019
Last Update Posted : May 16, 2019